Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Generation Bio Co GBIO

Healthcare Biotechnology
Generation Bio Co. is a biotechnology company. The Company is innovating non-viral genetic medicines to provide durable, redosable treatments for hundreds of millions of patients living with rare and prevalent diseases. The Company is developing two distinct and complementary platforms: a potent, highly selective cell-targeted lipid nanoparticle (ctLNP) delivery system and a novel immune-quiet... see more

Recent & Breaking News (NDAQ:GBIO)

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire February 23, 2023

Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 3, 2023

Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results

GlobeNewswire November 3, 2022

Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

GlobeNewswire September 22, 2022

Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

GlobeNewswire September 20, 2022

Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

GlobeNewswire August 4, 2022

Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

GlobeNewswire August 2, 2022

Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

GlobeNewswire July 18, 2022

Generation Bio Announces Update to Its GMP Manufacturing Strategy

GlobeNewswire June 21, 2022

Generation Bio to Present at the 2022 Jefferies Healthcare Conference

GlobeNewswire June 2, 2022

Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

GlobeNewswire May 5, 2022

Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

GlobeNewswire April 5, 2022

Generation Bio to Participate in 42nd Annual Cowen Health Care Conference

GlobeNewswire March 2, 2022

Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

GlobeNewswire February 24, 2022

Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer

GlobeNewswire February 10, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO

PR Newswire January 6, 2022

Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 5, 2022

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Generation Bio Co. - GBIO

PR Newswire December 16, 2021

Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program

GlobeNewswire December 14, 2021

Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results

GlobeNewswire November 10, 2021